Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
AMINE DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONIST ACTIVITY
Document Type and Number:
WIPO Patent Application WO/2007/125952
Kind Code:
A1
Abstract:
Disclosed is a compound represented by the formula (I) below, a pharmaceutically acceptable salt thereof, or a solvate of any of them. (I) In the formula, R1 represents an optionally substituted lower alkyl group; Y represents -S(O)n- (wherein n is 1 or 2) or -CO-; R2 represents a hydrogen or a lower alkyl; R7 represents a hydrogen or a lower alkyl; X represents a lower alkylene, a lower alkenylene, an arylene, a cycloalkylene or the like; and Z represents a lower alkyl, an optionally substituted hydrocarbon ring group, an optionally substituted heterocyclic group or the like.

Inventors:
OKUNO TAKAYUKI (JP)
KOUYAMA NAOKI (JP)
SAKAGAMI MASAHIRO (JP)
Application Number:
PCT/JP2007/058938
Publication Date:
November 08, 2007
Filing Date:
April 25, 2007
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHIONOGI & CO (JP)
OKUNO TAKAYUKI (JP)
KOUYAMA NAOKI (JP)
SAKAGAMI MASAHIRO (JP)
International Classes:
C07C311/05; A61K31/18; A61K31/381; A61K31/40; A61K31/415; A61K31/4164; A61K31/4184; A61K31/42; A61K31/423; A61K31/425; A61K31/426; A61K31/427; A61K31/428; A61K31/437; A61K31/44; A61K31/4402; A61K31/4409; A61K31/4436; A61K31/4439; A61K31/4453; A61K31/451; A61K31/47; A61K31/472; A61K31/473; A61K31/495; A61K31/4965; A61K31/50; A61K31/501; A61K31/502; A61K31/505; A61K31/5375; A61K31/538; A61K31/553; A61P3/04; A61P9/04; A61P9/12; A61P15/00; A61P25/08; A61P25/20; A61P25/24; A61P43/00; C07C311/07; C07C317/36; C07D207/325; C07D211/14; C07D213/38; C07D213/74; C07D213/82; C07D215/38; C07D217/04; C07D217/14; C07D217/22; C07D219/10; C07D231/38; C07D233/61; C07D235/30; C07D237/20; C07D237/22; C07D237/34; C07D239/42; C07D241/20; C07D261/14; C07D261/20; C07D263/58; C07D265/30; C07D265/36; C07D267/14; C07D275/02; C07D277/28; C07D277/62; C07D277/82; C07D295/12; C07D295/18; C07D333/36; C07D333/40; C07D333/66; C07D333/72; C07D403/04; C07D409/04; C07D413/04; C07D417/12; C07D498/04; C07D513/04
Domestic Patent References:
WO2007002126A12007-01-04
WO2001037826A12001-05-31
WO2000064880A12000-11-02
WO2001002379A12001-01-11
WO2001037826A12001-05-31
WO1999055667A11999-11-04
WO2005097738A12005-10-20
WO2006014482A12006-02-09
WO1997020823A21997-06-12
WO2006001318A12006-01-05
WO2007002126A12007-01-04
WO2006001318A12006-01-05
WO2005121107A12005-12-22
WO2005121107A12005-12-22
WO1996016542A11996-06-06
Foreign References:
JP2003503486A2003-01-28
JP2004501120A2004-01-15
JP2002541245A2002-12-03
US20060293341A12006-12-28
JP2006124387A2006-05-18
US20060293341A12006-12-28
US20070060598A12007-03-15
Other References:
PEPTIDES, vol. 18, 1997, pages 445
TRENDS IN PHARMACOLOGICAL SCIENCES, vol. 18, 1997, pages 372
PEPTIDES, vol. 18, 1997, pages 445
INUI, A. ET AL., ENDOCRINOLOGY, vol. 131, 1992, pages 2090 - 2096
See also references of EP 2017261A4
Attorney, Agent or Firm:
TAKAYAMA, Hirotsugu et al. (Intellectual Property Department,12-4, Sagisu 5-chome,Fukushima-ku, Osaka-shi, Osaka02, JP)
Download PDF: